Hayley Lewis - Net Worth and Insider Trading

Hayley Lewis Net Worth

The estimated net worth of Hayley Lewis is at least $0 dollars as of 2024-12-28. Hayley Lewis is the See Remarks of Zosano Pharma Corp and owns about 1,422 shares of Zosano Pharma Corp (ZSANQ) stock worth over $0. Details can be seen in Hayley Lewis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hayley Lewis has not made any transactions after 2021-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Hayley Lewis

To

Hayley Lewis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hayley Lewis owns 2 companies in total, including Zosano Pharma Corp (ZSANQ) , and KalVista Pharmaceuticals Inc (KALV) .

Click here to see the complete history of Hayley Lewis’s form 4 insider trades.

Insider Ownership Summary of Hayley Lewis

Ticker Comapny Transaction Date Type of Owner
ZSANQ Zosano Pharma Corp 2021-06-04 See Remarks
KALV KalVista Pharmaceuticals Inc 2015-08-03 See Remarks

Hayley Lewis Latest Holdings Summary

Hayley Lewis currently owns a total of 1 stock. Hayley Lewis owns 1,422 shares of Zosano Pharma Corp (ZSANQ) as of June 4, 2021, with a value of $0.

Latest Holdings of Hayley Lewis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZSANQ Zosano Pharma Corp 2021-06-04 1,422 0.00 0

Holding Weightings of Hayley Lewis


Hayley Lewis Form 4 Trading Tracker

According to the SEC Form 4 filings, Hayley Lewis has made a total of 1 transactions in Zosano Pharma Corp (ZSANQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zosano Pharma Corp is the sale of 49 shares on June 4, 2021, which brought Hayley Lewis around $1,384.

Insider Trading History of Hayley Lewis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hayley Lewis Trading Performance

GuruFocus tracks the stock performance after each of Hayley Lewis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hayley Lewis is -52.77%. GuruFocus also compares Hayley Lewis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hayley Lewis within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hayley Lewis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hayley Lewis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -40 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -37.95 LIMIT LIMIT LIMIT LIMIT LIMIT

Hayley Lewis Ownership Network

Ownership Network List of Hayley Lewis

No Data

Ownership Network Relation of Hayley Lewis

Insider Network Chart

Hayley Lewis Owned Company Details

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Hayley Lewis is the See Remarks of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zosano Pharma Corp Insider Transactions

No Available Data

Hayley Lewis Mailing Address

Above is the net worth, insider trading, and ownership report for Hayley Lewis. You might contact Hayley Lewis via mailing address: C/o Carbylan Therapeutics, Inc., 3181 Porter Drive, Palo Alto Ca 94304.

Discussions on Hayley Lewis

No discussions yet.